Search Results

Showing results 191-201 of 210 for 'Community'

  • acwis_37410209234.jpg
    Weizmann in Focus, Episode 2: Plant Research for a Healthier Planet

    In the second episode of <em>Weizmann in Focus</em>, CEO Dave Doneson discusses how the Institute’s plant scientists are tackling the challenge of global food security. These innovative researchers are figuring out how plants can better resist drought, provide higher-quality nutrition, and more. Dave spotlights a breakthrough by Prof. Jonathan Gressel, who discovered a method of killing a parasitic weed that was destroying corn crops in sub-Saharan Africa.

  • Yeda_SK_1.jpg
    South Korea Invests in Weizmann Institute of Science Biomed

    Two South Korean concerns have committed to investing a total of $12 million in spinout companies incorporated by Yeda Research and Development Co. Ltd., the technology transfer arm of the Weizmann Institute of Science. The first investment – $2 million by Yozma Group Asia – is in On-Sight Medical Inc., jointly owned by Yeda, New York University (NYU), and related parties. For the second, the Korean group BioLeaders Corporation – in which Yozma Group Asia is an investor – has committed to investing $10 million in a new spinout firm that will develop an anti-cancer therapy developed by Weizmann Institute scientists.

  • Screen Shot 2019-03-21 at 9.18.22 AM.png
    2018 Midwest Gala Dinner – Highlights

    The Midwest Region’s annual Gala Dinner took place at The Geraghty in Chicago with over 600 guests in attendance. Local civic and community leaders came together to honor Michael Polsky, Founder and CEO of Invenergy. A dedicated philanthropist and energy industry pioneer, Mr. Polsky received the Weizmann Leadership Award. The evening’s program, emceed by ABC 7 reporter Janet Davies, also consisted of presentations by University of Chicago President Robert Zimmer and Prof. Avigdor Scherz, Department of Plant and Environmental Sciences, who discussed his cutting-edge cancer research. Chaired by Janet and Steven Anixter and JoAnn Anixter Silva, the highly successful gala raised over $1.3 million in support of the Weizmann Institute.

  • Yeda_SK_1.jpg
    South Korea Firm to Invest $10m in Weizmann Scientists’ Anti-Cancer Drug

    An anti-cancer therapy that has been developed by scientists at the Weizmann Institute of Technology will get a $10 million investment from a South Korean biopharmaceutical company that is traded on the Korea Stock Exchange. This is the Korean firm’s first investment in an Israeli venture, the Weizmann Institute said in a statement.

  • jpost-erez.jpg
    Israeli Firm Offers Hope to Cancer Patients Beyond Standard Care

    <em>The Jerusalem Post</em> reports on a company established by a Weizmann Institute alum, Nir Erez, who left a job in big pharma to find a way to help cancer sufferers. His firm, Trial-In Pharma, connects patients to 20,000 clinical trials and compassionate use treatments worldwide.

  • Institut Curie protontherapy center.jpg
    Historic Partnership Between the Weizmann Institute of Science and Institut Curie

    On March 22, the Weizmann Institute of Science in Rehovot, Israel, and Institut Curie in Paris, France, two major world-class research institutes, signed an historic partnership that will allow their teams to work closely together to improve knowledge in the field of life sciences, particularly in the areas of physics and chemistry, and most specifically - in the field of cancer research. This is a milestone in the history of these two institutes that have been working together for 15 years, particularly in the field of biophysics.

  • acwis_54085086544.jpg
    Philanthropy in Action: The 13th Annual Gruber Award

    On April 2, Patricia Gruber presented the 13th annual Gruber Award for Scientific Excellence to the Weizmann Institute’s Dr. Sivan Refaely-Abramson. Established by Patricia and her late husband, Peter, through their Gruber Foundation, the three-year award recognizes brilliant early-career Weizmann scientists.

  • WEIZMANN-IN-FOCUS-PLAY-SCREEN-website-eps4.jpg